Tetsuyuki Igarashi
Sapporo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan.
Journal: International journal of hematology
Published: November 07, 2025
Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine-venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net.
Journal: Blood cancer journal
Published: May 12, 2025
Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group.
Journal: Haematologica
Published: December 09, 2023
Novel stratification for newly diagnosed acute myeloid leukaemia treated with venetoclax-based therapy in the real world: Hokkaido Leukemia Net Study.
Journal: British journal of haematology
Published: November 10, 2023
Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia.
Journal: International journal of hematology
Published: October 08, 2022
Primary diffuse large B-cell lymphoma of the breast in a male patient with Sjögren's syndrome
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 10, 2020
Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Journal: Medicine
Published: September 03, 2020
Primary biliary cholangitis complicated by primary hepatic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: December 17, 2019
Molecular diagnostics of a single drug-resistant multiple myeloma case using targeted next-generation sequencing.
Journal: OncoTargets and therapy
Published: October 23, 2015
Decrease of B-type natriuretic peptide to less than 200 pg/mL predicts longer survival in cardiac immunoglobulin light chain amyloidosis.
Journal: International journal of hematology
Published: February 10, 2015
Human herpesvirus 6 encephalitis in a patient with glucocorticoid therapy for inflammatory abdominal aortic aneurysm
Journal: Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology
Published: May 20, 2014
Last Updated: 09/26/2026